Ocular Therapeutix (OCUL) Operating Leases (2019 - 2026)
Ocular Therapeutix (OCUL) reported Operating Leases of $3.47 million for Q2 2026, down 21.4% from $4.41 million a year earlier and down 18.1% from the prior quarter.
Powered by 
Analysis
Ocular Therapeutix (OCUL) Operating Leases (2019 - 2026) Analysis & Trends
At the end of FY2025, Ocular Therapeutix posted Operating Leases of $2.82 million, down 47.3% from FY2024.
- Operating Leases has declined for three consecutive years, with a five-year compound annual growth rate of -17.9% (FY2020 to FY2025).
- By year, Operating Leases came in at $5.35 million in FY2024 (-22.3%), $6.88 million in FY2023 (-20.7%), $8.68 million in FY2022 (+46.5%) and $5.92 million in FY2021 (-21.5%).
- Five-year quarterly Operating Leases spans a low of $2.82 million in Q4 2025 and a high of $8.68 million in Q4 2022.
- Year over year, Operating Leases has now declined in each of the last 11 quarters, with an average decline of 26.7% over the last eight quarters.
- The high point for year-over-year Operating Leases in five years was Q3 2023 (growth of 57.3%); the low point was Q4 2025 (a decline of 47.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $4.23 million (Q1 2026), $2.82 million (Q4 2025) and $3.63 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Ocular Therapeutix | 1.45 Bn | -895.10 Mn | 11.46 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.47 Mn |
| Mar 31, 2026 | 4.23 Mn |
| Dec 31, 2025 | 2.82 Mn |
| Sep 30, 2025 | 3.63 Mn |
| Jun 30, 2025 | 4.41 Mn |
| Mar 31, 2025 | 4.87 Mn |
| Dec 31, 2024 | 5.35 Mn |
| Sep 30, 2024 | 5.59 Mn |
| Jun 30, 2024 | 6.10 Mn |
| Mar 31, 2024 | 6.41 Mn |
| Dec 31, 2023 | 6.88 Mn |
| Sep 30, 2023 | 7.25 Mn |
| Jun 30, 2023 | 7.69 Mn |
| Mar 31, 2023 | 8.11 Mn |
| Dec 31, 2022 | 8.68 Mn |
| Sep 30, 2022 | 4.61 Mn |
| Jun 30, 2022 | 5.00 Mn |
| Mar 31, 2022 | 5.47 Mn |
| Dec 31, 2021 | 5.92 Mn |
| Sep 30, 2021 | 6.36 Mn |
API Access
Ocular Therapeutix Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=OCUL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "OCUL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=OCUL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();